American International Group, Inc. Replimune Group, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Replimune Group, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 24,367 shares of REPL stock, worth $203,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,367

Previous 24,577 0.85%

Holding current value

$203,951

Previous $207,000 3.86%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.87 - $9.31 $1,442 - $1,955	-210 Reduced 0.85%	24,367 $199,000
Q4 2023 Feb 13, 2024	BUY	$6.75 - $16.18 $25,947 - $62,195	3,844 Added 18.54%	24,577 $207,000
Q3 2023 Nov 13, 2023	BUY	$15.96 - $22.18 $17,970 - $24,974	1,126 Added 5.74%	20,733 $354,000
Q2 2023 Aug 04, 2023	SELL	$15.65 - $24.1 $45,651 - $70,299	-2,917 Reduced 12.95%	19,607 $455,000
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $57,893 - $96,346	3,312 Added 17.24%	22,524 $397,000

Q4 2022 Feb 10, 2023	SELL	$17.09 - $27.91 $1,196 - $1,953	-70 Reduced 0.36%	19,212 $522,000
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $80,542 - $109,197	5,163 Added 36.57%	19,282 $333,000
Q2 2022 Aug 12, 2022	SELL	$13.32 - $19.98 $11,628 - $17,442	-873 Reduced 5.82%	14,119 $247,000
Q1 2022 May 13, 2022	SELL	$15.24 - $29.75 $12,359 - $24,127	-811 Reduced 5.13%	14,992 $255,000
Q4 2021 Feb 11, 2022	SELL	$25.43 - $34.25 $12,028 - $16,200	-473 Reduced 2.91%	15,803 $428,000
Q3 2021 Nov 12, 2021	BUY	$28.98 - $39.54 $36,949 - $50,413	1,275 Added 8.5%	16,276 $482,000
Q2 2021 Aug 13, 2021	BUY	$28.5 - $39.37 $27,759 - $38,346	974 Added 6.94%	15,001 $576,000
Q1 2021 May 07, 2021	BUY	$30.22 - $45.57 $5,953 - $8,977	197 Added 1.42%	14,027 $428,000
Q4 2020 Feb 12, 2021	BUY	$23.5 - $52.65 $31,960 - $71,604	1,360 Added 10.91%	13,830 $528,000
Q3 2020 Nov 04, 2020	BUY	$18.85 - $27.0 $36,606 - $52,434	1,942 Added 18.45%	12,470 $287,000
Q2 2020 Aug 12, 2020	BUY	$9.76 - $25.95 $25,151 - $66,873	2,577 Added 32.41%	10,528 $262,000
Q1 2020 May 04, 2020	SELL	$8.9 - $19.08 $1,539 - $3,300	-173 Reduced 2.13%	7,951 $79,000
Q4 2019 Feb 05, 2020	BUY	$11.61 - $17.21 $9,276 - $13,750	799 Added 10.91%	8,124 $117,000
Q3 2019 Nov 08, 2019	SELL	$10.01 - $16.87 $510 - $860	-51 Reduced 0.69%	7,325 $102,000
Q2 2019 Aug 13, 2019	SELL	$12.51 - $17.28 $1,338 - $1,848	-107 Reduced 1.43%	7,376 $108,000
Q1 2019 May 06, 2019	BUY	$10.26 - $16.24 $26,275 - $41,590	2,561 Added 52.03%	7,483 $114,000
Q4 2018 Feb 13, 2019	SELL	$9.97 - $15.57 $388 - $607	-39 Reduced 0.79%	4,922 $49,000
Q3 2018 Nov 09, 2018	BUY	$14.99 - $22.14 $74,365 - $109,836	4,961 New	4,961 $80,000

Others Institutions Holding REPL

# of Institutions

154

Shares Held

66.1M

Call Options Held

79.4K

Put Options Held

102K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $413M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Replimune Group, Inc. Transaction History